Skip to main content

Leiters Awarded a Group Purchasing Agreement by Comprehensive Pharmacy Services - Yahoo Finance

DENVER, May 13, 2020 /PRNewswire/ -- Leiters announced today that it has entered into a strategic arrangement with the newly reorganized group purchasing organization affiliate of Comprehensive Pharmacy Services, LLC (CPS),  Comprehensive Purchasing Alliance, LLC (CPA), to be the leading 503B service provider to CPA's hospital members.

Leiters Logo (PRNewsfoto/Leiters)

Leiters, founded in 1926, is a market leading FDA-registered 503B outsourcing provider of high-quality hospital and ophthalmology compounded sterile preparations. Leiters provides outsourced medications across the continuum of healthcare including, hospitals, surgery centers, physician offices and clinics. 

Through this agreement, Leiters will provide CPA members with its full portfolio of 503B compounded sterile preparations including operating room products such as pre-filled syringes, pain medicines, and a pharmacy fill service for the ON-Q* Pain Relief system. Also covered by the agreement are ophthalmology medicines, including FDA-compliant repackaged Avastin®.

"CPS did its homework and selected Leiters based on quality and reliability of supply plus our ever-expanding portfolio. We are excited to be strategically aligned with CPS and their GPO, Comprehensive Purchasing Alliance, LLC, to service their members and deliver quality ready-to-use pharmaceuticals," said Marc Mullen, Executive Vice President Sales & Marketing for Leiters.

CPS is one of the nation's leading provider of pharmacy solutions supporting pharmacy leadership by providing optimized pharmacy best practices and innovative technology solutions. CPS was founded nearly 50 years ago, employs over 2,500 pharmacy experts and serves over 800 U.S. hospitals.

"The high quality of compounded sterile products and competitive prices that Leiters provides means that we can deliver these medications to our clients reliably and cost effectively," said Frank Segrave, Chairman and CEO of CPS. "This is another example of CPS' commitment to create value for our clients through opportunities such as our GPO."

"We look forward to working with Leiters to provide greater access and improved service for compounded and ready-made pharmaceuticals through our Comprehensive Purchasing Alliance," said Mike VanderPol, Division Vice President of Purchasing for CPS.

About Leiters
Leiters, founded in 1926, is a trusted FDA-registered 503B outsourcing provider of high-quality hospital and ophthalmology compounded sterile preparations. We are committed to providing healthcare professionals and their patients with high quality outsourced medications. Our team of experts in sterile pharmaceutical manufacturing, repackaging and compounding provide a sophisticated understanding of what it takes to elevate quality and consistency of supply in pharmaceutical outsourcing. We combine a highly experienced team, with robust processes, in a new state-of-the-art outsourcing facility, to ensure delivery of the highest quality medicines. All sterile preparations are produced under the Human Drug Outsourcing Facilities under 503B of the FD&C Act (503B Guidance) and follow Current Good Manufacturing Practices (cGMP). To learn more about how we're Compounding Health™ please visit www.leiters.com

Contact:
Kari Cashmore, Leiters
(720) 414-7216
Kari.Cashmore@Leiters.com

About Comprehensive Pharmacy Services, LLC
Founded nearly 50 years ago and employing over 2,500 pharmacy professionals, Comprehensive Pharmacy Services, LLC is one of the nation's largest providers of pharmacy services to more than 800 hospitals and healthcare facilities nationwide. CPS helps their clients tackle complex problems such as hyperinflated drug costs, specialty pharmacy, ambulatory/retail strategy, operational effectiveness, interim leadership needs, and telepharmacy solutions. In addition, they address 340B programs, a variety of compliance concerns and much more. CPS helps pharmacy leaders drive cost, quality and safety improvements across the continuum of care. For more information, visit cpspharm.com.

Contact:
Rod Recor, Comprehensive Pharmacy Services, LLC
(901) 748-0470
Rod.Recor@cpspharm.com

 

View original content to download multimedia:https://ift.tt/3czcjNP

SOURCE Leiters



Labels:

Comments

Post a Comment

Popular posts from this blog

Apple's new iCloud feature for iPhone, iPad and Mac will have you kissing Dropbox goodbye - CNET

xmlns="http://www.w3.org/1999/xhtml" id="emailbody" style="margin:0 2em;font-family:Georgia,Helvetica,Arial,Sans-Serif;line-height:140%;font-size:13px;color:#000000;"> Apple's new iCloud feature for iPhone, iPad and Mac will have you kissing Dropbox goodbye - CNET xmlns=""> Apple's new iCloud feature for iPhone, iPad and Mac will have you kissing Dropbox goodbye - CNET Posted: 13 Apr 2020 03:29 PM PDT Jason Cipriani/CNET At the end of March , Apple gave  iPhone , iPad  and  Mac owners yet another option to share folders of important documents and photos. Instead of relying on third-party service such as Dropbox , a software update from Apple  added the ability to use your iCloud Drive storage to share a folder, whether it's a work presentation, a collection of GIFs between friends or your kid's remote learning homework.  Not too long ago, Dropbox ...
Post a Comment
Read more

HPAPI Drug Manufacturing Trends - Contract Pharma

Highly potent API (HPAPI) drugs make up a growing percentage of the small molecule drug development pipeline and this group of products is growing faster than the overall small molecule segment, 1 largely due to their usefulness in cancer treatments. Many of these drugs have accelerated timelines for approval and commercial development, which can be challenging for drug developers to keep up with. On the front-end, new technologies such as in-silico prediction tools contribute to shortening candidate selection, 2 while Artificial Intelligence (AI) has already brought a first candidate into clinical development. 3 On the back-end, regulatory drug approval timelines are being increasingly shortened: when analyzing drug approvals in 2019, almost three-quarters of drugs approved (71%) were approved under Priority Review. 4 A related trend is increasing competition in the oncology field, with 80% of new IND’s now belonging to small, emerging or virtual biotech companies. 5 These firms o...
Post a Comment
Read more

“How to make your Google/Nest smart speakers, displays, and cameras listen for suspicious sounds - TechHive” plus 4 more

xmlns="http://www.w3.org/1999/xhtml" id="emailbody" style="margin:0 2em;font-family:Georgia,Helvetica,Arial,Sans-Serif;line-height:140%;font-size:13px;color:#000000;"> “How to make your Google/Nest smart speakers, displays, and cameras listen for suspicious sounds - TechHive” plus 4 more How to make your Google/Nest smart speakers, displays, and cameras listen for suspicious sounds - TechHive NOAA's Cloud Systems Help Manage Telework Capabilities - MeriTalk Google Launches Fully Integrated Google Cloud VMware Engine - Solutions Review Facebook's voice synthesis AI generates speech in 500 milliseconds - VentureBeat Systemware, Inc. Brings Enhanced Content Services Capabilities to the Cloud With New Platform Update - EnterpriseTalk xmlns=""> How to make your Google/Nest smart speakers, displays, and cameras listen for suspicious sounds - TechHive P...
Post a Comment
Read more